Success Metrics

Clinical Success Rate
58.3%

Based on 7 completed trials

Completion Rate
58%(7/12)
Active Trials
2(13%)
Results Posted
43%(3 trials)
Terminated
5(33%)

Phase Distribution

Ph phase_1
2
13%
Ph phase_3
3
20%
Ph not_applicable
3
20%
Ph phase_2
6
40%

Phase Distribution

2

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 2Efficacy & side effects
6(42.9%)
Phase 3Large-scale testing
3(21.4%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

53.8%

7 of 13 finished

Non-Completion Rate

46.2%

6 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(7)
Terminated(6)

Detailed Status

Completed7
Terminated5
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
58.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (14.3%)
Phase 26 (42.9%)
Phase 33 (21.4%)
N/A3 (21.4%)

Trials by Status

completed747%
recruiting213%
terminated533%
withdrawn17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06589596Phase 1

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Recruiting
NCT03635164Phase 1

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Completed
NCT04045470Not Applicable

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Recruiting
NCT03474458Phase 2

A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy

Terminated
NCT04224740Phase 2

Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

Completed
NCT04778475Not Applicable

Impact of More Frequent PT Services

Completed
NCT04328246Phase 3

Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation

Terminated
NCT05302947

COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU

Completed
NCT03354754Phase 2

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

Terminated
NCT03345407Phase 2

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Terminated
NCT00397345Phase 3

TroVax Renal Immunotherapy Survival Trial

Completed
NCT04349241Phase 3

Efficacy and Safety of Favipiravir in Management of COVID-19

Completed
NCT03377426Phase 2

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)

Withdrawn
NCT01921569Not Applicable

Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis

Terminated
NCT01624311Phase 2

Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15